Phenanthrene-enriched extract from Eulophia macrobulbon using subcritical dimethyl ether for phosphodiesterase-5A1 inhibition
- PMID: 35397625
- PMCID: PMC8994770
- DOI: 10.1038/s41598-022-08553-x
Phenanthrene-enriched extract from Eulophia macrobulbon using subcritical dimethyl ether for phosphodiesterase-5A1 inhibition
Abstract
Eulophia macrobulbon (E.C.Parish & Rchb.f.) Hook.f. contains a natural PDE5A1 inhibitor, phenanthrene, 1-(4'-hydroxybenzyl)-4,8- dimethoxyphenanthrene-2,7-diol (HDP), a potential agent for the treatment of erectile dysfunction. The aim of this study was to improve the extraction efficiency of HDP from E. macrobulbon by using a more environmentally friendly extraction method, subcritical liquid dimethyl ether extraction (sDME), instead of classical solvent extraction (CSE) and ultrasound-assisted extraction (UAE). The efficiency and quality of the extracts obtained were evaluated using the following criteria: %process yield; solvent amount; extraction time; temperature; %HDP content by LC-MS, bioactivity as inhibition of phosphodiesterase-5A1 (PDE5A1) by radio-enzymatic assay; and chemical profiles by LC-QTOF-MS. sDME provided the highest content of HDP in the extract at 4.47%, much higher than the use of ethanol (0.4-0.5%), ethyl acetate (1.2-1.7%), or dichloromethane (0.7-1.4%). The process yield for sDME (1.5-2.7%) was similar to or lower than the other solvents (0.9-17%), but as long as the process yield is not prohibitively low, the concentration is a more important measure for clinical use. The optimal conditions for sDME extraction were: Extraction time, 40 min; 200% water as co-solvent; sample-to-solvent ratio of 1:8; temperature, 35 °C. Phenanthrene aglycone and glycoside derivatives were the major constituents of the sDME extracts and lesser amounts of phenolic compounds and sugars. The inhibition of PDE5A1 by sDME (IC50 0.67 ± 0.22 µg/ml) was tenfold more potent than ethanolic extract and other extraction methods, suggesting a high probability of clinical efficacy. Thus, sDME was a more efficient, faster, solvent-saving and environmentally friendly extraction method and more selective for phenanthrene when extracted from E. macrobulbon.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Phenanthrenes from Eulophia macrobulbon as Novel Phosphodiesterase-5 Inhibitors.Nat Prod Commun. 2017 Jan;12(1):79-82. Nat Prod Commun. 2017. PMID: 30549830
-
Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension.Phytomedicine. 2018 Nov 15;50:157-165. doi: 10.1016/j.phymed.2018.05.014. Epub 2018 May 22. Phytomedicine. 2018. PMID: 30466974
-
Vasorelaxant and Hypotensive Effects of an Ethanolic Extract of Eulophia macrobulbon and Its Main Compound 1-(4'-Hydroxybenzyl)-4,8-Dimethoxyphenanthrene-2,7-Diol.Front Pharmacol. 2018 May 22;9:484. doi: 10.3389/fphar.2018.00484. eCollection 2018. Front Pharmacol. 2018. PMID: 29872393 Free PMC article.
-
Green aspects, developments and perspectives of liquid phase microextraction techniques.Talanta. 2014 Feb;119:34-45. doi: 10.1016/j.talanta.2013.10.050. Epub 2013 Oct 29. Talanta. 2014. PMID: 24401382 Review.
-
Review on Extraction of Phenolic Compounds from Natural Sources Using Green Deep Eutectic Solvents.J Agric Food Chem. 2021 Jan 27;69(3):878-912. doi: 10.1021/acs.jafc.0c06641. Epub 2021 Jan 15. J Agric Food Chem. 2021. PMID: 33448847 Review.
References
-
- Peak TC, Kammel K, Sangkum P, Tan RBW, Hellstrom WJG. Reference Module in Biomedical Sciences. Elsevier; 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources